3.3 Long-acting GLP1 receptor agonists: Once-weekly 3.3.1 Semaglutide SMG is an analog of long-acting GLP-1, mainly used to control T2DM, and is also suitable for promoting weight loss in people with mild obesity (95, 96)
Tracking your progress with GLP-1 drops Measuring results helps determine whether your technique and dosing are optimized, or whether adjustments are needed
Consultado el 22 de diciembre de 2025: Semaglituda semanal en adultos con sobrepeso u obesidad, The New England Journal of Medicine
Some researchers prefer to inject on rest days, as the first 24 to 48 hours after injection tend to produce the most pronounced GI effects
This is evident in animal models of diabetes and is highly suggested in human diabetes
Mantn presionado el botn de la pluma durante 10 segundos para asegurarte de que se administre toda la dosis